5 - Yingli Green Energy Holding - NYSE:YGE 4 - Turkish Investment Fund - NYSE:TKF 3 - Fremont General - NYSE:FMT 2 - Qiagen NV - NASDAQ:QGEN 1 - Dendreon - NASDAQ:DNDN
Yingli Green Energy Holding Company Limited, (NYSE:YGE) through its subsidiary, Baoding Tianwei Yingli New Energy Resources Co., Ltd., engages in the design, development, marketing, manufacturing, and installation and sale of photovoltaic products in the People's Republic of China and internationally. Its products include polysilicon ingots and wafers, photovoltaic cells and modules, and integrated photovoltaic systems.
* Solar energy company, Amtech said it has received a $4.9 million follow-on solar order from a recent new customer based in
The Turkish Investment Fund, Inc. (NYSE:TKF) operates as a non-diversified, closed-end management investment company. It invests primarily in equity securities of Turkish corporations. The fund's portfolio comprises investments in airlines, commercial banks, construction materials, diversified financial services, food and staples retailing, food products, health care providers and services, industrial conglomerates, machinery, media, multiline retail, and real estate sectors.
* Morgan Stanley Investment Management, Inc. announced on July 20th that it will post selected information regarding the Morgan Stanley Investment Management-sponsored Institutional Closed-End Funds, to its public web-site at www.morganstanley.com/im on July 23, 2007. The posting will include information relating to each Fund's top 10 portfolio holdings for the month ended June 30, 2007. Morgan Stanley Investment Management intends to make top 10 holdings information for its Institutional Closed-End Funds available approximately 15 business days following the end of the most recent month. TKF is among Morgan Stanley Institutional Closed-End Funds. Shares of TKF lost .92 cents or 4.30% on the NYSE on Monday, 7/30.
Fremont General Corporation (NYSE:FMT) operates as the holding company for Fremont Investment & Loan, which engages in commercial and residential real estate lending business in the United States. It originates non-prime or sub-prime residential real estate loans through independent brokers on a wholesale basis, which are primarily sold to third party investors; and commercial real estate loans, including bridge, construction, and permanent loans on a nationwide basis.
* American Home Mortgage trading was halted by the New York Stock Exchange on Monday after shares plummeted on word the real estate investment trust suspended its 70-cent per-share quarterly dividends due to margin calls and write-downs. The news peripherally battered other lenders, including sub-prime lenders NovaStar Financial, lately off 16% to $2.59, and Fremont General, down .36 cents or 5.26% on the news Monday.
QIAGEN N.V., (NASDAQ:QGEN) through its subsidiaries, engages in the development, manufacture, and marketing of products for the handling, separation, purification, and subsequent use of nucleic acids and proteins. It offers sample and assay consumable products, which include disposable sample processing devices and/or other proprietary technologies; reagents and buffers; and a technical handbook that includes a detailed protocol and background information.
* On Friday July 27, 2007 HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the calculating agent for the HealthShares(TM) Diagnostics Index, that effective at the opening of trading on Monday July 30, CR Bard Inc. will replace Digene Corp. in the HealthShares(TM) Diagnostics Index. QIAGEN N.V. acquired all the outstanding shares of Digene Corp. QGEN shares were up .39 cents or 2.32% on NASDAQ on Monday, 7/30.
Dendreon, Corp. (NASDAQ:DNDN) a biotechnology company, engages in the discovery, development, and commercialization of therapeutics that harness the immune system to fight cancer. Its product portfolio includes active cellular immunotherapy, monoclonal antibody, and small molecule product candidates to treat various cancers.
* According to BusinessWeek Online late last week, prostate cancer patient advocates are up in arms these days over the FDA's controversial refusal in May to approve Dendreon's Provenge without further clinical trials, which could take a year or more to complete. Provenge is a novel cancer vaccine meant to prime the body's immune system to attack tumors, and if approved would have been the first new treatment in more than 20 years for advanced, stage-4 prostate cancer, which is almost always fatal. Some 30,000 men die each year in the
The daily HIGH FIVE stocks are determined by the company's proprietary, internal algorithmic calculators. The result is five securities that are the most sought after to borrow, and have proven to be the hottest stocks to short that day.
LocateStock.com is the premier electronic securities lending company providing revolutionary, real-time, hard-to-borrow stock locates and market data to hedge funds and professional traders seeking an efficient and private way to borrow stock associated with short sales. The Company recently launched LocateStock TV, a daily financial news show that highlights stock inventory that is available for short sellers to legally borrow and stay in compliance with Regulation SHO.
For an in-depth market analysis on each individual, hard to borrow stock, tune in daily to LocateStock TV, on http://www.locatestock.com/pressrelease.html
CONTACT: Locate Stock, Inc. e-mail: pressrelease@locatestock.com Tel: +1 201 332 6800
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2007 M2 COMMUNICATIONS LTD
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home